116 related articles for article (PubMed ID: 35409)
1. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
[TBL] [Abstract][Full Text] [Related]
2. Fibrinolytic activity in utero and bleeding complications with intrauterine contraceptive devices.
Bonnar J; Kasonde K; Haddon M; Hassanein MK; Allington MJ
Br J Obstet Gynaecol; 1976 Feb; 83(2):160-4. PubMed ID: 148902
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen-fibrin degradation products in menstrual blood from women with normal and excessive menstrual losses.
Hahn L; Rybo G
Acta Obstet Gynecol Scand; 1975; 54(2):119-27. PubMed ID: 1136717
[TBL] [Abstract][Full Text] [Related]
4. Coagulation factors and fibrinolytic proteins in menstrual fluid collected from normal and menorrhagic women.
Rees MC; Cederholm-Williams SA; Turnbull AC
Br J Obstet Gynaecol; 1985 Nov; 92(11):1164-8. PubMed ID: 2415154
[TBL] [Abstract][Full Text] [Related]
5. Comparative quantitation of menstrual blood loss with the Lippes Loop, Dalkon Shield, and copper T intrauterine devices.
Israel R; Shaw ST; Martin MA
Contraception; 1974 Jul; 10(1):63-71. PubMed ID: 4442266
[TBL] [Abstract][Full Text] [Related]
6. On the correlation between local fibrinolytic activity in menstrual fluid and total blood loss during menstruation and effects of desmopressin.
Edlund M; Blombäck M; He S
Blood Coagul Fibrinolysis; 2003 Sep; 14(6):593-8. PubMed ID: 12960614
[TBL] [Abstract][Full Text] [Related]
7. Fibrin and platelets in menstrual discharge before and after the insertion of an intrauterine contraceptive device.
Christiaens GC; Sixma JJ; Haspels AA
Am J Obstet Gynecol; 1981 Aug; 140(7):793-98. PubMed ID: 7258261
[TBL] [Abstract][Full Text] [Related]
8. Blood coagulation, fibrinolysis and plasma proteins in women with normal and with excessive menstrual blood loss.
Hahn L; Cederblad G; Rybo G; Pehrsson NG; Bengtsen KK
Br J Obstet Gynaecol; 1976 Dec; 83(12):974-80. PubMed ID: 1009035
[TBL] [Abstract][Full Text] [Related]
9. Fibrin degradation products in sera of women with normal menstruation and menorrhagia.
Basu HK
Br Med J; 1970 Jan; 1(5688):74-5. PubMed ID: 5411448
[TBL] [Abstract][Full Text] [Related]
10. No increased systemic fibrinolysis in women with heavy menstrual bleeding.
Wiewel-Verschueren S; Knol HM; Lisman T; Bogchelman DH; Kluin-Nelemans JC; van der Zee AG; Mulder AB; Meijer K
J Thromb Haemost; 2014 Sep; 12(9):1488-93. PubMed ID: 24954113
[TBL] [Abstract][Full Text] [Related]
11. Consumption of fibrinolytic proteins in menstrual fluid from women with normal menstrual blood loss.
Cederholm-Williams SA; Rees MC; Turnbull AC
J Clin Pathol; 1984 Aug; 37(8):879-81. PubMed ID: 6540788
[TBL] [Abstract][Full Text] [Related]
12. The response of endometrial blood vessels to intrauterine contraceptive devices: an electron microscopic study.
Sheppard BL; Bonnar J
Br J Obstet Gynaecol; 1980 Feb; 87(2):143-54. PubMed ID: 7362802
[TBL] [Abstract][Full Text] [Related]
13. The effect of tranexamic acid on measured menstrual loss and endometrial fibrinolytic enzymes in dysfunctional uterine bleeding.
Gleeson NC; Buggy F; Sheppard BL; Bonnar J
Acta Obstet Gynecol Scand; 1994 Mar; 73(3):274-7. PubMed ID: 8122512
[TBL] [Abstract][Full Text] [Related]
14. Menstrual blood loss and fibrin degradation products.
Cole SK; Clarkson AR
Br Med J; 1972 Jan; 1(5792):78-9. PubMed ID: 5007072
[TBL] [Abstract][Full Text] [Related]
15. Increased fibrinolytic activity in the endometrium of patients using copper-iud (gravigard).
Larsson B; Liedholm P; Astedt B
Int J Fertil; 1975; 20(2):77-80. PubMed ID: 3481
[TBL] [Abstract][Full Text] [Related]
16. Quantification of menstrual flow by weighing protective pads in women with normal, decreased or increased menstruation.
Gudmundsdottir BR; Hjaltalin EF; Bragadottir G; Hauksson A; Geirsson RT; Onundarson PT
Acta Obstet Gynecol Scand; 2009; 88(3):275-9. PubMed ID: 19137461
[TBL] [Abstract][Full Text] [Related]
17. Role of prostaglandins in IUD-associated uterine bleeding--effect of a prostaglandin synthetase inhibitor (ibuprofen).
Roy S; Shaw ST
Obstet Gynecol; 1981 Jul; 58(1):101-6. PubMed ID: 7243136
[TBL] [Abstract][Full Text] [Related]
18. Production of fibrinolytic enzymes by macrophages on intrauterine contraceptive devices.
Foley ME; Jenkins DM; McNicol GP
Br J Obstet Gynaecol; 1978 Jul; 85(7):551-6. PubMed ID: 678491
[TBL] [Abstract][Full Text] [Related]
19. The fibrinolytic enzyme system in normal menstruation and excessive uterine bleeding and the effect of tranexamic acid.
Dockeray CJ; Sheppard BL; Daly L; Bonnar J
Eur J Obstet Gynecol Reprod Biol; 1987 Apr; 24(4):309-18. PubMed ID: 2953634
[TBL] [Abstract][Full Text] [Related]
20. Hormonal profile in IUD users.
Souka AR; Rahman H; Osman M; Mohei Y; Rizk M
Contracept Deliv Syst; 1981 Oct; 2(4):303-10. PubMed ID: 12336991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
